French medical client boosts Telnet Holding

Posted by Llama 3 70b on 21 October 2026

Telnet Holding Reports 2.1% Growth in Operating Revenue for First Nine Months of 2026

Telnet Holding’s consolidated activity indicators through the end of September 2026 reveal a slight 2.1% increase in operating revenue, reaching 63.292 MTND. The company’s revenue structure has undergone a notable shift, with the Product Engineering R&D division now accounting for 83.2% of total operating revenue, up from 76.8% in the same period last year.

Key Drivers of Performance

This growing dominance is primarily driven by a new French client in the medical sector, whose contribution has helped improve the group’s EBITDA ratio.

Conversely, other business segments experienced declines:

  • PLM Services & Network Integration: Recorded a 28.1% drop, falling to 6.080 MTND.
  • New Space Technologies: Followed a similar downward trend, with a 23.1% decrease to 4.561 MTND. This figure reflects the recognition of revenue from services delivered under a strategic global contract with an African country.

Improved Profitability and Operational Efficiency

The group’s EBITDA margin stood at 17.34% over the nine-month period, a significant improvement from 14.13% a year earlier. This enhancement is attributed to a 1.8% reduction in operating expenses, which decreased to 52.315 MTND, alongside the growth in operating revenue.

  • Personnel costs rose by 5.7% to 40.556 MTND.
  • Other operating expenses fell by 13.1% to 10.511 MTND.

Telnet Holding is gaining operational efficiency, largely due to the higher profitability of its R&D activities compared to integration services.

Strong Stock Performance

Overall, Telnet Holding is maintaining its course. With a year-to-date return exceeding 81.5%, the stock ranks among the top-performing investments on the market since the beginning of the year.